Your browser doesn't support javascript.
loading
Conversion to supportive care with biosimilar pegfilgrastim-cbqv enables budget-neutral expanded access to R-CHOP treatment in non-Hodgkin lymphoma.
McBride, Ali; MacDonald, Karen; Abraham, Ivo.
Affiliation
  • McBride A; Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, AZ, USA; University of Arizona Cancer Center, Tucson, AZ, USA; Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, AZ, USA.
  • MacDonald K; Matrix45, Tucson, AZ, USA.
  • Abraham I; Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, AZ, USA; University of Arizona Cancer Center, Tucson, AZ, USA; Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, AZ, USA; Matrix45, Tucson, AZ, USA. Electronic address: iabraham@matrix45.com.
Leuk Res ; 106: 106591, 2021 07.
Article in En | MEDLINE | ID: mdl-33957339
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Antineoplastic Combined Chemotherapy Protocols / Drug Costs Type of study: Health_economic_evaluation / Prognostic_studies Limits: Humans Language: En Journal: Leuk Res Year: 2021 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Antineoplastic Combined Chemotherapy Protocols / Drug Costs Type of study: Health_economic_evaluation / Prognostic_studies Limits: Humans Language: En Journal: Leuk Res Year: 2021 Document type: Article Affiliation country: United States Country of publication: United kingdom